@article{fea0bbc7bcc343259fda5dce98e42b1e,
title = "ERS Scientific Working Group 09.04, {"}Psychologists and behavioural scientists{"}: the next step towards multidisciplinary respiratory care",
keywords = "anxiety, association, asthma, copd, depression, disease, health-care, impact, medicine, quality, DEPRESSION, QUALITY, ANXIETY, MEDICINE, IMPACT, DISEASE, ASTHMA, HEALTH-CARE, ASSOCIATION, COPD",
author = "{von Leupoldt}, A. and L.J. Brighton and J. Peters and E. Volpato and M. Verkleij and A. Hutchinson and M. Heijmans and I. Farver-Vestergaard and D. Langer and M.A. Spruit and {ERS Scientific Working Group 09.04}",
note = "Funding Information: Support statement: A. von Leupoldt is supported by research grants from the Research Foundation – Flanders (FWO), Belgium (GOA4516N and GOA3718N), by an infrastructure grant from the FWO and the Research Fund KU Leuven, Belgium (AKUL/19/06; I011320N), and by the {\textquoteleft}{\textquoteleft}Asthenes{\textquoteright}{\textquoteright} long-term structural funding Methusalem grant (METH/15/ 011) by the Flemish Government, Belgium. L.J. Brighton is supported through a National Institute for Health Research (NIHR) Career Development Fellowship (CDF-2017-10-009) held by Matthew Maddocks. Funding information for this article has been deposited with the Crossref Funder Registry. Funding Information: Conflict of interest: A. von Leupoldt reports grants from Research Foundation – Flanders (FWO) Belgium, Research Foundation – Flanders (FWO) and Research Fund KU Leuven, Belgium, and Flemish Government, Belgium, during the conduct of the study. L.J. Brighton has nothing to disclose. J. Peters has nothing to disclose. E. Volpato has nothing to disclose. M. Verkleij has nothing to disclose. A. Hutchinson has nothing to disclose. M. Heijmans has nothing to disclose. I. Farver-Vestergaard reports personal fees from AstraZeneca, Boehringer Ingelheim, Novartis and Roche, outside the submitted work. D. Langer has nothing to disclose. M.A. Spruit reports grants from Netherlands Lung Foundation and Stichting Astma Bestrijding, grants and personal fees from AstraZeneca and Boehringer Ingelheim, outside the submitted work.",
year = "2020",
month = sep,
day = "1",
doi = "10.1183/13993003.01881-2020",
language = "English",
volume = "56",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "3",
}